• BUSINESS Stem-cell trial: The biotherapeutics firm Neuralstem in Rockville, Maryland, has received permission from the US Food and Drug Administration to inject neural stem cells into the spinal cords of 12 patients with amyotrophic lateral sclerosis (Lou Gehrig's disease). The trials -the first stem-cell approach for the condition -will focus on safety rather than efficacy, and are expected to take place Climate clamour: Ahead of United Nations climate meetings in preparation for the Copenhagen summit, a flurry of reports warned last week of
The 10-year "new biology" initiative should be supported by new dedicated funding, not from existing agency research budgets, the report from the Board on Life Sciences urged. Report co-author Keith Yamamoto of the University of California, San Francisco, estimates that at least US$2 billion per year should be earmarked for the scheme.
the impact of climate change on the developing world. Alongside calls for strong political leadership came the World Bank 2010 Development Report, a biennial assessment which estimated that poor nations would need more than US$500 billion a year to adapt to climate change and develop low-carbon technology -in line with earlier UN estimates. And in a letter to the British Medical Journal and The Lancet, doctors warned of a "global health catastrophe" resulting from climate change -with effects ranging from widespread malnutrition to the spread of tropical diseases. • AWARDS The US geothermal industry is anticipating a boost in investment, as the Department of Energy prepares to announce recipients of US$400 million in stimulus grants for research and demonstration projects in the sector. Geothermal energy is a consistent source of clean power, but electricity investors are not used to risking the large up-front cost of exploratory drilling. The department's money will "help drill a lot of holes", says Ethan Zindler, of consultants New Energy Finance in London. Geothermal's contribution to US electricity generation (see chart) has been constant for more than a decade. But the country's 3 gigawatts of installed capacity -the largest of any nation -could double over the next ten years if projects already planned work out, says Karl Gawell, executive director of the Geothermal Energy Association in Washington DC.
In July, Magma Energy, based in Vancouver, Canada, raised more than Can$110 million (US$103 million) in an initial public offering. Private geothermal developer Ram Power, in Reno, Nevada, raised Can$180 million by private subscriptions and is expecting to merge with three Canadian geothermal firms. But in California, a US$17-million project was halted earlier this month after operator AltaRock Energy in Sausalito encountered problems at its drilling site.
• RESEARCH Resignation: The head of research at the Swiss Federal Institute of Technology (ETH), Zurich, has resigned over concerns that spectroscopic data published by his research group in 1999 and 2000 had been faked. Peter Chen, a physical organic chemist, stepped down as vice-president for research after a commission that he had requested in January concluded that two papers and a doctoral thesis contained falsified data. Chen denies any involvement in handling the data and is retaining his post as a professor. For more, see http://tinyurl. com/eth-resig Planck on course: The Planck telescope enjoyed a successful test run, said the European Space Agency (ESA), as it geared up to map the sky's cosmic microwave background. ESA reported on 17 September that preliminary results showed excellent data quality.
Stem-cell collaboration:
California and Germany are collaborating on stem-cell research. The California Institute for Regenerative Medicine and the German Federal Ministry of Education and Research announced plans last week to work together on joint research projects, focusing on immunology. The agreement makes it easier for researchers in both jurisdictions to apply for joint funding. The California stem-cell agency already has international collaborations with Australia, Canada, Japan, Spain and the United Kingdom.
Plague death: A molecular geneticist at the University of Chicago died on 13 September after exposure to an attenuated strain of Yersinia pestis, the bacterium that causes plague. Malcolm Casadaban, 60, was European appointment: Gérard de Nazelle, a former global manager for research and innovation at Shell, has been appointed the first director of the European Institute of Innovation and Technology, at its Budapest headquarters.
at Emory University, Georgia, subject to approval from the university's patient-safety board. For more, see http://tinyurl.com/ Neuralstem working with a strain of the bacterium that has been used in vaccines in some countries and is approved by the US Centers for Disease Control and Prevention in Atlanta, Georgia, for laboratory studies. He died about 12 hours after being admitted to hospital. The bacterium was not identified as the cause of death until 18 September.
The director of the environmental energy department at Lawrence Berkeley National Laboratory in California has been nominated to head the US Advanced Research Projects Agency-Energy.
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Stem cells: The US National Institutes of Health (NIH) began accepting applications on 21 September to evaluate which human embryonic stem cells will be eligible for federal dollars. A panel of nine scientists, lawyers and ethicists will check that the submissions meet new requirements for informed consent from embryo donors. The working group has not yet appraised any cell lines -including the 21 lines approved under former US President George W. Bush, which must be reassessed -and will start considering particular lines after scientists submit their petitions on the NIH website.
